Overcoming chemotherapy resistance by targeting the insulin-like growth factor 1 (IGF-1) axis in a patient with metastatic castration-resistant prostate cancer and pituitary adenoma: Killing two birds with one stone

Jue Wang
Jue Wang
Article information